Mayne Pharma Group Shares Surge After Promising Half-Year Results
![News Image for Mayne Pharma Group Shares Surge After Promising Half-Year Results](https://www.fool.com.au/wp-content/uploads/2024/07/lab-fist-bump-16.9-1200x675.jpg)
Mayne Pharma Group shares surged 19.7% after announcing strong preliminary half-year results, projecting significant revenue and earnings growth for FY 2025.
The S&P/ASX 300 Index (ASX: XKO) is down 0.3% today, but ASX 300 healthcare stock Mayne Pharma Group Ltd (ASX: MYX) is racing in the other direction.